DUPONT ACA VANCOMYCIN (VANC) METHOD— 510(k) K945125

Substantially Equivalent

The DU Pont Co.

FDA 510(k) clearance K945125 for DUPONT ACA VANCOMYCIN (VANC) METHOD, Substantially Equivalent on 1995-03-10. Applicant: The DU Pont Co..

Clearance details

Applicant
The DU Pont Co.
Product code
Code LEH
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Wilimington, DE, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.